Melonie Fleshman
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 56 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 23 manufacturers reported payments, led by AbbVie at 31.3% of the total. 2025 is the largest year on record at $307, 2.7 times the $113 reported in 2021.
Across 56 payments — averaging $17.26 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$302
- AstraZeneca$67
- Astellas Pharma US Inc$66
- ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$55
- Teva Pharmaceuticals USA, Inc.$48
- Merck$47
- plus $382 from 17 others
What the payments were for
- Food & beverage$967100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
How this compares
$967 in reported general payments places this provider in the 65th percentile of 3,248 family providers in South Carolina.
Other family in Greer
- Sarah ValerioGreer$76K
- Sara ChristieGreenville$229K
- Kara Cooper GilmerAnderson$127K
- Jessica BellEasley$96K
- Carrie HendersonGreenville$91K
- Mary WilliamsColumbia$67K
- Michelle StrongGreenville$55K
- Karen McKerihanSummerville$54K
- Doris ReidSimpsonville$25K
- Hailey AtkinsonIrmo$24K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.